Insider Trades35 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 379 | $9.45 | $1.8B | -11.06% | +123.58% | $3.6K | -0.61% | 10b5-1 | Buy Now |
| Apr 6, 2026 | Sell | VIR | Backer Marianne De | President and CEO | 72,559 | $9.16 | $1.8B | -11.06% | +123.58% | $664.4K | -7.11% | 10b5-1 | Buy Now |
| Mar 23, 2026 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 7,711 | $9.12 | $1.8B | -11.06% | +123.58% | $70.3K | -11.08% | 10b5-1 | Buy Now |
| Feb 24, 2026 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 1,430 | $9.53 | $1.8B | -11.06% | +123.58% | $13.6K | -2.01% | 10b5-1 | Buy Now |
| Feb 24, 2026 | Sell | VIR | Jason O'Byrne | EVP & Chief Financial Officer | 1,634 | $9.53 | $1.8B | -11.06% | +123.58% | $15.6K | -0.99% | 10b5-1 | Buy Now |
| Feb 24, 2026 | Sell | VIR | Mark Eisner | EVP and Chief Medical Officer | 3,505 | $9.69 | $1.8B | -11.06% | +123.58% | $34.0K | -1.12% | 10b5-1 | Buy Now |
| Feb 24, 2026 | Sell | VIR | Backer Marianne De | Chief Executive Officer | 14,762 | $9.53 | $1.8B | -11.06% | +123.58% | $140.7K | -1.43% | 10b5-1 | Buy Now |
| Feb 24, 2026 | Sell | VIR | Verneuil Vanina De | EVP, General Counsel, Corp Sec | 16,817 | $9.77 | $1.8B | -11.06% | +123.58% | $164.2K | -6.56% | 10b5-1 | Buy Now |
| Feb 23, 2026 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 1,829 | $7.45 | $1.8B | -11.06% | +123.58% | $13.6K | -1.49% | 10b5-1 | Buy Now |
| Feb 23, 2026 | Sell | VIR | Mark Eisner | EVP and Chief Medical Officer | 2,089 | $7.45 | $1.8B | -11.06% | +123.58% | $15.6K | -0.77% | 10b5-1 | Buy Now |
| Feb 23, 2026 | Sell | VIR | Jason O'Byrne | EVP & Chief Financial Officer | 2,089 | $7.45 | $1.8B | -11.06% | +123.58% | $15.6K | -0.76% | 10b5-1 | Buy Now |
| Feb 23, 2026 | Sell | VIR | Verneuil Vanina De | EVP, General Counsel, Corp Sec | 4,445 | $7.45 | $1.8B | -11.06% | +123.58% | $33.1K | -1.82% | 10b5-1 | Buy Now |
| Feb 23, 2026 | Sell | VIR | Backer Marianne De | Chief Executive Officer | 19,039 | $7.45 | $1.8B | -11.06% | +123.58% | $141.9K | -1.17% | 10b5-1 | Buy Now |
| Feb 13, 2026 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 1,530 | $7.79 | $1.8B | -11.06% | +123.58% | $11.9K | -3.10% | 10b5-1 | Buy Now |
| Nov 17, 2025 | Sell | VIR | Jason O'Byrne | EVP & Chief Financial Officer | 6,799 | $5.56 | $1.8B | -11.06% | +123.58% | $37.8K | -5.79% | — | Buy Now |
| Nov 5, 2025 | Sell | VIR | Verneuil Vanina De | EVP, General Counsel, Corp Sec | 2,385 | $5.16 | $1.8B | -11.06% | +123.58% | $12.3K | -2.96% | 10b5-1 | Buy Now |
| Nov 3, 2025 | Sell | VIR | Verneuil Vanina De | EVP and General Counsel | 1,365 | $5.86 | $1.8B | -11.06% | +123.58% | $8.0K | -1.67% | — | Buy Now |
| Jul 15, 2025 | Sell | VIR | Mark Eisner | EVP and Chief Medical Officer | 10,382 | $5.47 | $1.8B | -11.06% | +123.58% | $56.8K | -4.65% | 10b5-1 | Buy Now |
| Apr 3, 2025 | Sell | VIR | Backer Marianne De | Chief Executive Officer | 79,712 | $5.95 | $1.8B | -11.06% | +123.58% | $474.2K | -9.39% | — | Buy Now |
| Feb 26, 2025 | Sell | VIR | Verneuil Vanina De | EVP and General Counsel | 7,373 | $9.14 | $1.8B | -11.06% | +123.58% | $67.4K | -8.49% | 10b5-1 | Buy Now |
| Feb 24, 2025 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 1,562 | $9.45 | $1.8B | -11.06% | +123.58% | $14.8K | -1.77% | — | Buy Now |
| Feb 24, 2025 | Sell | VIR | Verneuil Vanina De | EVP and General Counsel | 5,140 | $9.45 | $1.8B | -11.06% | +123.58% | $48.6K | -3.17% | — | Buy Now |
| Feb 24, 2025 | Sell | VIR | Ann M. Hanly | EVP & Chief Technology Officer | 14,168 | $9.45 | $1.8B | -11.06% | +123.58% | $133.9K | -10.73% | — | Buy Now |
| Feb 24, 2025 | Sell | VIR | Backer Marianne De | Chief Executive Officer | 16,122 | $9.45 | $1.8B | -11.06% | +123.58% | $152.4K | -1.20% | — | Buy Now |
| Feb 13, 2025 | Sell | VIR | Brent Sabatini | SVP, Chief Accounting Officer | 1,562 | $9.15 | $1.8B | -11.06% | +123.58% | $14.3K | -5.25% | — | Buy Now |
| Dec 2, 2024 | Sell | VIR | Verneuil Vanina De | EVP and General Counsel | 76 | $8.22 | $1.8B | -11.06% | +123.58% | $624.728 | -0.13% | — | Buy Now |
| Nov 6, 2024 | Sell | VIR | Verneuil Vanina De | EVP and General Counsel | 4,397 | $10.11 | $1.8B | -11.06% | +123.58% | $44.5K | -7.16% | 10b5-1 | Buy Now |
| Nov 1, 2024 | Sell | VIR | Verneuil Vanina De | EVP and General Counsel | 3,750 | $8.62 | $1.8B | -11.06% | +123.58% | $32.3K | -2.91% | 10b5-1 | Buy Now |
| Apr 3, 2024 | Sell | VIR | Backer Marianne De | Chief Executive Officer | 72,995 | $9.46 | $1.8B | -11.06% | +123.58% | $690.4K | -9.71% | — | Buy Now |
| Apr 1, 2024 | Sell | VIR | Ann M. Hanly | EVP & Chief Technology Officer | 2,711 | $10.05 | $1.8B | -11.06% | +123.58% | $27.3K | -2.01% | — | Buy Now |
| Mar 27, 2024 | Sell | VIR | Sung Lee | EVP & Chief Financial Officer | 6,008 | $9.89 | $1.8B | -11.06% | +123.58% | $59.4K | -5.64% | — | Buy Now |
| Feb 22, 2024 | Sell | VIR | Ann M. Hanly | EVP & Chief Technology Officer | 12,296 | $10.05 | $1.8B | -11.06% | +123.58% | $123.5K | -5.80% | — | Buy Now |
| Feb 22, 2024 | Sell | VIR | Phillip Pang | EVP & Chief Medical Officer | 14,568 | $10.05 | $1.8B | -11.06% | +123.58% | $146.3K | -5.50% | — | Buy Now |
| Feb 16, 2024 | Sell | VIR | Phillip Pang | EVP & Chief Medical Officer | 3,321 | $10.24 | $1.8B | -11.06% | +123.58% | $34.0K | -1.24% | — | Buy Now |
| Jan 2, 2024 | Buy | VIR | Phillip Pang | EVP & Chief Medical Officer | 80,000 | $1.38 | $1.8B | -11.06% | +123.58% | $110.3K | +13.00% | — | Buy Now |